HARROW HEALTH INC's ticker is HROW and the CUSIP is 415858109. A total of 91 filers reported holding HARROW HEALTH INC in Q2 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $193,793 | -95.3% | 13,486 | -93.8% | 0.00% | -100.0% |
| Q2 2023 | $4,119,837 | +39.7% | 216,378 | +55.2% | 0.00% | 0.0% |
| Q1 2023 | $2,950,085 | +43.4% | 139,418 | 0.0% | 0.00% | +100.0% |
| Q4 2022 | $2,057,810 | +22.3% | 139,418 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $1,683,000 | +65.8% | 139,418 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $1,015,000 | +6.7% | 139,418 | 0.0% | 0.00% | – |
| Q1 2022 | $951,000 | -45.2% | 139,418 | -30.5% | 0.00% | -100.0% |
| Q4 2021 | $1,734,000 | -4.9% | 200,693 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $1,824,000 | -18.0% | 200,693 | -16.2% | 0.00% | 0.0% |
| Q2 2021 | $2,225,000 | +504.6% | 239,463 | +339.4% | 0.00% | – |
| Q1 2021 | $368,000 | +214.5% | 54,492 | +219.0% | 0.00% | – |
| Q4 2020 | $117,000 | +64.8% | 17,084 | +35.8% | 0.00% | – |
| Q3 2020 | $71,000 | +18.3% | 12,583 | +9.4% | 0.00% | – |
| Q2 2020 | $60,000 | – | 11,503 | +164228.6% | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 7 | -97.7% | 0.00% | – |
| Q1 2019 | $1,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 3,140,000 | $29,171,000 | 4.84% |
| Ophir Asset Management Pty Ltd | 1,670,817 | $15,522,000 | 2.73% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 378,389 | $3,515,000 | 1.16% |
| Birchview Capital, LP | 180,000 | $1,672,000 | 1.00% |
| Diametric Capital, LP | 82,443 | $766,000 | 0.55% |
| Precision Wealth Strategies, LLC | 65,530 | $609,000 | 0.52% |
| Uniplan Investment Counsel, Inc. | 507,602 | $4,715,000 | 0.28% |
| BARD ASSOCIATES INC | 86,315 | $802,000 | 0.26% |
| EAM Investors, LLC | 142,272 | $1,322,000 | 0.20% |
| Zebra Capital Management LLC | 15,786 | $147,000 | 0.17% |